CRISPR Therapeutics AG’s public offering of 5,000,000 shares

CRISPR Therapeutics AG, a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, and Goldman Sachs & Co. LLC., Piper Jaffray & Co. and…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Solana Policy Institute’s Proposal to Issue Securities on Public Blockchain

Mattress Warehouse’s Acquisition of 176 New Stores

Copley Acquisition Corp.’s $172.5 Million Initial Public Offering

Virgo’s R$161 Million Debentures Issuance

SS Comercio de Cosmeticos e Produtos de Higiene Pessoal’s R$70 Million Commercial Notes Issuance

Elebar X Financial Trust’s US$2,5 Million Issuance

SEB’s Lease Agreement for its New Baltic Headquarters in Tallin

Sunrise Real Estate’s Sale of a Property near Warsaw

Enterprise Investors’ Acquisition of CM Internus

Bidvest Group’s Acquisition of Citron Hygiene

Tasaheel’s EGP 2.5 Billion Bond Issuance

Money Fellows’ $13 Million Financing Round

Sunset Hospitality Group’s Investment Round

CVC’s Investment in Dream Games

Beko’s €125 Million Syndicated Facility Financing

Mahindra & Mahindra’s Acquisition of a Stake in SML Isuzu

Tata Electronics Private Limited’s Setting Up of Semiconductor Fabs in India

Ather Energy’s Initial Public Offering

Littler Survey Reveals Top Workplace Issues

Fieldfisher Enters Poland with Two Office Openings

LawaL Legal & Tax Advisory Launches German Desk

Breon Peace, Former U.S. Attorney, Rejoins Cleary Gottlieb

Former GE Healthcare, Fresenius Litigation & Compliance Leader Pat Murphy Joins King & Spalding in Washington, D.C.

Cozen O’Connor Adds Prominent Class Action Litigator Erica W. Rutner to its Litigation Department

CRISPR Therapeutics AG’s public offering of 5,000,000 shares

Standard 1 Year Membership Required

Author: Paolo Bossi

Standard 1 Year Membership Required